国产99久久久国产精品潘金莲,,,

Parks
Parks

High Reward  Special Biomedical Policies

New Drug R&d

Enterprises entering the phase I, II and III clinical trials of new drugs will be rewarded up to 3 million yuan, 5 million yuan and 10 million yuan respectively; for those who has completed phase I, phase II and phase III clinical trials of new drugs will be awarded a maximum of 1 million yuan, 1.5 million yuan and 2 million yuan respectively;

? For new drug projects that start clinical research and purchase liability insurance for drug clinical trial, subsidy shall be given according to the maximum 50% of liability insurance premium;

? For projects that entrust CRO/CDMO with no investment relationship to carry out R&D services, 5% of the contract amount will be subsidized, up to 10 million yuan;

? For those who have obtained the drug registration certificate, a maximum reward of 10 million yuan will be given according to the drug registration classification standard;

? A single enterprise can get up to 20 million yuan of funding for new drug R&D every year.


Medical Device

? Enterprises that have newly obtained the first registration certificate of class II and class III medical devices, the maximum reward is 1 million yuan and 2 million yuan respectively;

? A single enterprise's annual subsidy for medical devices can reach up to 10 million yuan.

International Certification and Others

? For those newly registered and certified by FDA, EMA, PMDA and other organizations, which have been exported to corresponding countries, the maximum reward for each product is 1 million yuan, and the maximum reward for a single enterprise is 5 million yuan;

? Generic drug consistency evaluation: for the top three generic drugs in the country that have passed the consistency evaluation, a one-time subsidy of up to 4 million yuan will be given to each variety, and a single enterprise's annual subsidy can reach up to 10 million yuan;

? High end preparations: for the high-end preparations with national key development, the highest reward of 2 million yuan will be given for the first approval of a single variety.

Public Service Platform

? Those who have been newly recognized as municipal and/or provincial new R&D institution will be awarded a maximum reward of 1 million yuan and 1.5 million yuan respectively at one time;

?Those who have been recognized as provincial and national key laboratory will be awarded a maximum reward of 1 million yuan and 3 million yuan respectively;

? 5 million yuan will be awarded to those who have been recognized as national enterprise technology center;

? Those who have been recognized as provincial manufacturing innovation centers will be rewarded with 5 million yuan, and those upgraded to national level will be rewarded with another 5 million yuan;

? The new R & D institutions that have accepted the comprehensive evaluation can get a subsidy of up to 1 million yuan;

? Non clinical drug safety evaluation institutions, drug (including medical devices) clinical trial institutions, provincial and national clinical medical research centers / hospitals will be given a maximum one-time reward of 1 million yuan.

Introduction and Cultivation of Enterprises

? For the newly established biomedical project, the maximum reward is 2 million yuan for every 10 million US dollars or 100 million yuan of paid in registered capital (monetary contribution) before the project is put into operation. For the original or newly established projects that have been put into operation, a maximum reward of 3 million yuan will be given for every 10 million US dollars or 100 million yuan of newly increased registered capital. The maximum cumulative reward for a single project is 100 million yuan;

? For the projects that have obtained drug registration approval or class II or class III medical device registration certificate in the city and are industrialized in the city, 20% of the equipment investment will be awarded, and the maximum amount shall not exceed 20 million yuan;

? If the holder of drug or medical device marketing license entrusts the biomedical enterprises in this city to provide production services, the enterprises undertaking the entrusted production task shall be subsidized by varieties, with the maximum amount of 200,000 yuan for each variety, and the maximum amount of 1 million yuan per year for a single enterprise.

? 100,000 yuan will be awarded to the enterprises listed in the annual Top 10 of Zhuhai medical and health manufacturing industry; 500,000 yuan, 800,000 yuan, 1 million yuan and 2 million yuan will be awarded to the medical and health manufacturing enterprises whose annual main business income exceeds 1 billion yuan, 3 billion yuan, 5 billion yuan and 10 billion yuan respectively for the first time.

? For the pharmaceutical and medical device manufacturers whose annual sales revenue of a single variety exceeds 100 million yuan, 300 million yuan, 500 million yuan and 1 billion yuan for the first time, 100,000 yuan, 200,000 yuan, 300,000 yuan and 500,000 yuan will be awarded respectively.

Back to top
Visit Reservation
Wechat
Visit Reservation
* Name
* Mobile Phone
* Company
* Date of Visit
* Free Transfer Required
The specific arrangement will be contacted by the staff.
* Park
Required Area
伊人久久大香线蕉av桃花岛| 男男肠道灌水失禁play| 亚洲精品白浆高清久久久久久| 中文精品久久久久人妻不卡| 亚洲中文字幕无码久久2021| 最近免费中文字幕中文高清百度| 久久人人爽爽人人爽人人片av| 亚洲午夜av久久久精品影院色戒| 最近免费中文字幕mv免费高清版| 少妇AAA级久久久无码精品片| 公公的淫之手| 精品国产一区二区三区四区 | 在电梯伦流澡到高潮h男男| 同性双男a片又黄又刺激小说免费 精品呦啊呦v视频在线观看 | 日本免费a片| 女女互慰吃奶互揉高潮| 免费观看性欧美大片无片| 成人片色情免费观看网站| 国产综合精品一区二区三区| 男人放进女人阳道入口多深算正常 | 欧美18videosex性欧美| 久久人人爽人人爽人人片| 日韩精品无码一区aaa片| 国产98色在线 | 日韩 | 被背叛的田川的忧郁| 办公室扒开奶罩揉吮奶头a片 | 韩国年轻漂亮岳每4乱理| 亚洲中文字幕无码久久2021| 大肉大捧一进一出好爽视频mba| 在线观看的资源视频| 色戒无删减版| 中文字幕第一页| 性xxxfreexxxx国产| YING娃养成被C日记| 欧美在线观看| 欧美在线香蕉在线视频| 无码熟妇人妻AV在线影片| 久久久久无码国产精品一区| 在线视频免费观看www动漫 | 快穿之胸大喂奶h| 全彩调教本子h里番全彩无码|